Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kramar

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Bulletin Du Cancer|August 29, 2007
[Propensity score: interest and limits]Fabrice Kwiatkowski, Karem Slim, Pierre Verrelle, et al.
Biometrics|August 14, 2009
Utility-based optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trialsNadine Houede, Peter F Thall, Hoang Nguyen, et al.
Journal of Cancer Research and Clinical Oncology|May 4, 2013
Prognostic impact of LDH levels in patients with relapsed/refractory seminomaTom Powles, Caroline Bascoul-Mollevi, Andrew Kramar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survivalSylvaine Galiègue, Pierre Casellas, Andrew Kramar, et al.
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Predicting distant dissemination in patients with early breast cancerRodrigo Arriagada, Lars-Erik Rutqvist, Hemming Johansson, et al.
Statistics in Medicine|October 30, 2016
Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residualsJean-Marie Boher, Thomas Filleron, Roch Giorgi, et al.
Computer Methods and Programs in Biomedicine|December 15, 2015
Analysis of survival adjusted for quality of life using the Q-TWiST function: Interface in REmilie Bogart, Anaïs Jouin, Hélène Béhal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 20, 2015
Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapyMathieu Leclerc, Eric Lartigau, Thomas Lacornerie, et al.
Statistical Methods in Medical Research|February 26, 2014
Optimal scheduling of post-therapeutic follow-up of patients treated for cancer for early detection of relapsesSerge Ma Somda, Eve Leconte, Jean-Marie Boher, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2003
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimenMarc Ychou, Jacqueline Duffour, Andrew Kramar, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Bulletin Du Cancer|August 29, 2007
[Propensity score: interest and limits]Fabrice Kwiatkowski, Karem Slim, Pierre Verrelle, et al.
Biometrics|August 14, 2009
Utility-based optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trialsNadine Houede, Peter F Thall, Hoang Nguyen, et al.
Journal of Cancer Research and Clinical Oncology|May 4, 2013
Prognostic impact of LDH levels in patients with relapsed/refractory seminomaTom Powles, Caroline Bascoul-Mollevi, Andrew Kramar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survivalSylvaine Galiègue, Pierre Casellas, Andrew Kramar, et al.
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Predicting distant dissemination in patients with early breast cancerRodrigo Arriagada, Lars-Erik Rutqvist, Hemming Johansson, et al.
Statistics in Medicine|October 30, 2016
Goodness-of-fit test for monotone proportional subdistribution hazards assumptions based on weighted residualsJean-Marie Boher, Thomas Filleron, Roch Giorgi, et al.
Computer Methods and Programs in Biomedicine|December 15, 2015
Analysis of survival adjusted for quality of life using the Q-TWiST function: Interface in REmilie Bogart, Anaïs Jouin, Hélène Béhal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 20, 2015
Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapyMathieu Leclerc, Eric Lartigau, Thomas Lacornerie, et al.
Statistical Methods in Medical Research|February 26, 2014
Optimal scheduling of post-therapeutic follow-up of patients treated for cancer for early detection of relapsesSerge Ma Somda, Eve Leconte, Jean-Marie Boher, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2003
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimenMarc Ychou, Jacqueline Duffour, Andrew Kramar, et al.
Pageof 9